Skip to content

McKesson MCK Net Change in Cash

Net Change in Cash at other companies

Eli Lilly logo
Eli LillyLLY
-$1.99B-1,035%
Cardinal Health logo
Cardinal HealthCAH
$1.16B+340%
Cencora logo
CencoraCOR
-$2.59B-2,763%
AbbVie logo
AbbVieABBV
$4.16B+1,293%
Amneal Pharmaceuticals, Inc. logo
Amneal Pharmaceuticals, Inc.AMRX
-$108.53M-117%
Viatris logo
ViatrisVTRS
$457.7M+2,166%

Other financials

Income statement

See full
Revenue$96.3B+6.0%
Gross profit$4.0B+11.1%
Operating income$2.2B+35.1%
Net income$1.7B+33.5%
EPS (diluted)$13.65+37.6%

Balance sheet

See full
Cash & equivalents$4.0B-33.3%
Total debt$2.3B-74.2%
Total equity-$2.2B-4.7%
Total assets$82.3B+9.6%

Cash flow

See full
Operating cash flow$3.4B-55.8%
CapEx$111.0M-34.3%
Free cash flow$3.3B-56.3%

Valuation

See full
Market cap$89.39B-0.7%
Enterprise value$87.69B-11.0%
P/E18.8×-9.7×
P/S0.2×0.0×

Profitability

See full
Gross margin3.6%-0.1pp
Operating margin1.5%+0.3pp
Net margin1.2%+0.3pp
FCF margin1.4%-0.1pp

Returns & leverage

See full
Return on equity36%
Debt / equity
Current ratio0.9×0.0×

Where this comes from

Reported directly by McKesson in its filing.

Tagged under the XBRL concept us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect.

The official record: McKesson’s 10-Q, filed February 4, 2026, on SEC EDGAR. View the filing →

Ask your AI about McKesson's net change in cash.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is McKesson's net change in cash?
McKesson (MCK) reported net change in cash of -$1.06B in Q4 2025.
How has McKesson's net change in cash changed year-over-year?
McKesson's net change in cash increased by 14.1% year-over-year, from -$1.23B to -$1.06B.
What does net change in cash mean?
Total increase or decrease in cash during the period — the sum of operating, investing, financing cash flows plus FX effects.